ABSTRACT Inhalation histamine dose-response curves were constructed 15 minutes after inhalation of saline placebo or verapamil (4 mg) for eight patients with mild atopic asthma in a double blind, random manner. No significant change in baseline specific airways conductance occurred after inhalation of verapamil, though there was a significant decrease in sensitivity to histamine (increase in threshold of response) (p < 0-01). There was, however, an associated significant increase (p < 0*01) in the slopes of the subsequent histamine dose-response curves.
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Verapamil is a member of a group of drugs that have been termed calcium antagonists' or, more specifically, calcium channel blockers.2 In a variety of tissues, including airways smooth muscle, these drugs act by inhibiting membrane potential dependent calcium influx from the extracellular fluid, which would stimulate excitation-contraction coupling and thus muscle contraction. 3 Several groups of workers have observed a beneficial effect of calcium channel blockade in exercise induced bronchospasm.47 An inhibitory action of nifedipine on the bronchoconstrictor action of inhaled histamine has also been reported in mild asthma,8 but others have been unable to confirm such an effect for either nifedipine or verapamil.9 '°T hese studies used forced expiratory volume in one second (FEVy) as the index of airways calibre. The use of FEV, in pharmacological studies, however, has been questioned."I Not only are relatively large doses of drug needed to elicit a response, but the deep inspiration and forced expiration needed for the manoeuvre may themselves modify that response.
In the study we describe, specific airways conductance (sGaw) has been used as a more sensitive measure of change in airways calibre for obtaining graded, cumulative inhaled histamine dose-response curves after inhalation of placebo and of verapamil.
This has allowed us to obtain an estimate of the threshold of bronchoconstrictor response ("sensitivAddress for reprint requests: Dr EH Walters, C/o Asthma Research Unit, Sully Hospital, Penarth, South Glamorgan.
Accepted 16 April 1984 ity") of the airways and also the slope of the subsequent dose-response curve ("reactivity") '213 with these different pharmacological regimens.
Methods
Eight subjects with mild atopic asthma (six of them female; mean age 24, range 19-34 years) took part in the study after informed consent and ethical approval had been obtained. None were smokers and none required regular medication. In each patient the disease was well documented and controlled by occasional inhalations of a 8 adrenergic agonist drug only. On recruitment to the study all had an FEV, greater than 70% of the predicted normal value.
The first part of the study was performed double blind and in random order. Subjects attended the laboratory at the same time of day on two separate occasions, at least three days apart, and avoided all medication for at least 12 hours before each part of the experimental procedure. After sitting quietly in the laboratory for 30 minutes a measurement of sGaw was made. This was repeated after five minutes and the mean of these values was taken as the baseline for that day. After measurement of sGaw, subjects inhaled completely 4 
Results
No subject experienced side effects after inhaling verapamil. There was no significant difference in baseline sGaw between control and verapamil study days (table) . Inhalation of neither saline nor verapamil caused a significant change in sGaw over the 15 minute postinhalation observation period (ending about 30 minutes after the start of the drug inhalation). Verapamil caused a significant decrease in sensitivity to inhaled histamine (p < 0-01), the mean value of D20 increasing from 0-77 mg/ml after placebo to 4-30 mg/ml after verapamil. Once bronchoconstriction had occurred, however, the reactivity of the airways was significantly increased after verapamil, with an increase in the mean value of slope from -0-63 s-' kPa-' for control days to -1-52 s-' kPa-' after verapamil (p < 0.01) ( In the present study verapamil was shown to have complex influences on the action of inhaled histamine in a group of patients with mild asthma.
There was no overall effect on basal airways smooth muscle tone as reflected in sGaw, which confirms Walters, Banks, Fennerty, Davies the findings of several other groups. 4"'0 The sensitivity of the airways to inhaled histamine was significantly decreased, although most of these asthmatic subjects still remained more sensitive to histamine than normal'7 18 even after calcium channel blockade. Reactivity of the airways to histamine, however, increased after verapamil inhalation, so that its beneficial effect seen at low histamine concentrations largely disappeared when the concentration of inhaled histamine was increased.
The overall effect of calcium channel blockade on histamine inhalation that we have demonstrated in asthmatic subjects is very similar to the effect described by Farley and Miles'6 on acetylcholine induced airways smooth muscle contraction in vitro. The explanation may also be the same. Thus at low concentrations of inhaled histamine the bronchoconstrictor effect of histamine may be via electromechanical coupling within airways smooth muscle, and thus amenable to the inhibitory action of verapamil and nifedipine, while at high concentrations histamine may induce predominantly pharmacomechanical coupling, uninfluenced by calcium channel blockade. A recent report has indicated that at relatively high concentrations histamine does indeed induce predominantly pharmacomechanical coupling within airways smooth muscle. '9 The variable effect of calcium channel blockade on bronchoconstrictor responses, dependent as they seem to be on the dose of agonist, may explain the conflicting results reported when FEVI alone has been used to monitor responses. Williams et al reported a small but significant decrease in responsiveness to inhaled histamine in terms of PC20FEVI, although Patel9 10 was unable to confirm this. The beneficial effect at low concentrations of bronchoconstrictor agonist could well be missed by using this technique, which requires relatively large doses of drug to elicit the magnitude of change used for statistical purposes.
The inhibitory action of calcium channel blockers on exercise induced asthma47 has been cited as evidence that exercise in susceptible subjects may cause degranulation of mast cells, another calcium dependent mechanism.9 Another explanation is, however, possible. Those asthmatics who are responsive to exercise also tend to show bronchoconstriction at the lowest concentrations of inhaled agonist drug,20 which presumably then operates by electromechanical coupling. Possibly during exercise these individuals respond to similarly small concentrations of released mediators operating in the same potential dependent way. Of interest in this context is the observation that the effectiveness of calcium channel blockade in exercise induced bronchospasm is most evident when the change in airways calibre is 
